Business Wire

Larger World Courier Depot in Buenos Aires Offers Quadrupled Pharma Capacity

Share
WORLD-COURIER

Currently undergoing audits, the new Buenos Aires investigational drug storage depot and other facility expansions offer incomparable temperature-controlled infrastructure to global clinical trial customers

World Courier is pleased to announce that its newest Clinical Trial Supply Chain Services (CTSCS) investigational drug storage depot will open in May 2012 in Buenos Aires (Argentina) after having moved to larger purpose-built premises in response to strong customer demand. The ultra-modern 37,000 square foot (3,400 square meter) facility is currently undergoing external audits and customer visits in preparation for its opening early next month.

“Customer demand for clinical trial storage in Argentina and throughout Latin America continues to remain very strong,” says Carlos Jankowski, Global Executive Director for World Courier’s CTSCS Division. “An increasing number of pharmaceutical clients are recognizing the benefits that our local distribution solutions have provided over the past seven years including lower costs, fewer import permits and clearances, shorter lead times and consistent on-time deliveries, all managed by a single supplier within a fully GxP-compliant environment.”

This is World Courier’s third major expansion in Buenos Aires since its first depot opened in 2005 and will quadruple the storage capacity of the former facility.

Other CTSCS Expansions

World Courier has also undertaken other significant expansions throughout its CTSCS network over the past year.

The company’s thirteenth and largest facility opened in Singapore last September and now delivers the most comprehensive ‘one-stop’ ICH- and GxP-compliant transport, storage and distribution services currently available in Asia. The 135,000 square foot (12,500 square meter) storage facility accommodates over 800 clinical trial protocols in a state-of-the-art temperature-secure environment. Strategically situated adjacent to Changi Airport, one of Southeast Asia’s most active aviation hubs, it meets both local and intra-regional distribution needs.

Another of World Courier’s newer CTSCS facilities − a 25,000 square foot (2,300 square meter) facility located in Tokyo (Japan) − is now actively engaged in providing logistics services to the local clinical trial industry, offering customers direct access to the world’s second largest pharmaceutical market.

Company CTSCS facilities in São Paulo (Brazil), Santiago (Chile), Beijing (China), Bogotá (Colombia), Bengaluru (India), México City (México), Lima (Perú), Moscow (Russia) and Johannesburg (South Africa) have all similarly expanded, or are in the process of expanding their physical capabilities to meet increased client demand. All facilities are fully GMP-compliant, are staffed by full-time licensed pharmacists and host separate validated storage for controlled ambient (+15o C to +25o C), refrigerated (+2o C to +8o C), frozen (-20o C) and deep frozen (-70o C) product and materials.

“By bringing together infrastructure, knowledge, expertise and process control into a ‘single-supplier’ distribution model, we are helping researchers shorten their distribution timelines, reduce risk and minimize costs while assuring quality and regulatory compliance in some of the world’s most challenging and distant locations,” says Wayne Heyland, president of the World Courier group of companies. “We remain committed to delivering the solutions our customers need, both now and in the future.”

About World Courier

World Courier is the largest and most experienced specialty logistics provider in the world, operating a company-owned network of 137 ISO 9001-certified offices in 52 countries along with 13 GMP-compliant investigational drug storage facilities in key emerging and strategic locations. With a fully GxP-compliant transport and supply chain system in place network-wide, World Courier meets the most demanding industry and regulatory requirements for managing the time- and temperature-sensitive consignments of regulated and other industries. World Courier services are utilized by over 500 biopharmaceutical companies including each of the top 50 global players as well as by all major contract research organizations, clinical trial suppliers and central labs. On March 6, 2012, AmerisourceBergen announced a definitive agreement to purchase World Courier subject to certain regulatory reviews and other customary closing conditions. For more information, go to http://www.worldcourier.com .

About AmerisourceBergen

AmerisourceBergen is one of the world's largest pharmaceutical services companies serving the United States, Canada and selected global markets. Servicing both healthcare providers and pharmaceutical manufacturers in the pharmaceutical supply channel, the Company provides drug distribution and related services designed to reduce costs and improve patient outcomes. Service solutions include pharmacy automation, pharmaceutical packaging, reimbursement and pharmaceutical consulting services. With more than $80 billion in annual revenue, AmerisourceBergen is headquartered in Valley Forge, PA, and employs approximately 11,000 people. AmerisourceBergen is ranked #27 on the Fortune 500 list. For more information, go to www.amerisourcebergen.com .

Contact:

World Courier
Noel Foucart, + 32 2 712 50 80
Director, Global Marketing
nfoucart@worldcourier.be
www.worldcourier.com
or
AmerisourceBergen
Barbara Brungess, +1-610-727-7199
Vice President Corporate & Investor Relations
bbrungess@amerisourcebergen.com

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

IFF Completes Divestiture of Nitrocellulose Business9.5.2025 14:00:00 CEST | Press release

IFF (NYSE: IFF) today announced that it has completed the divestiture of its nitrocellulose business, including Walsrode Industrial Park in lower Saxony, Germany, to Czechoslovak Group (CSG). The business manufactures nitrocellulose strictly for industrial purposes, serving customers primarily in coatings and printing inks, and had been part of IFF’s Pharma Solutions business unit. “The divestiture of our nitrocellulose business builds upon our deleveraging journey and enables us to focus on our core businesses,” said Erik Fyrwald, IFF CEO. “I’d like to thank our nitrocellulose colleagues for their dedication and wish them continued success as part of CSG.” Welcome to IFF At IFF (NYSE: IFF), we make joy through science, creativity and heart. As the global leader in flavors, fragrances, food ingredients, health and biosciences, we deliver groundbreaking, sustainable innovations that elevate everyday products—advancing wellness, delighting the senses and enhancing the human experience.Le

Monument Re Transfers €1.4bn Greycastle Portfolio to RGA and Strengthens European Life Insurance Consolidation Platform9.5.2025 14:00:00 CEST | Press release

Monument Re Limited (“Monument”) announces today that it has transferred a legacy €1.4bn reinsurance portfolio, comprising annuity and other life insurance liabilities acquired as part of the 2020 Greycastle transaction, to RGA Americas Reinsurance Company, Ltd. (“RGA”). This transaction releases capital resources that Monument will redirect to its core strategy of consolidation in European life insurance markets. The transaction completed on 2May 2025 following approval by the Boards of Directors of both Monument and RGA and non-objection from the Bermuda Monetary Authority. Monument has taken significant steps in recent months to strengthen its business operations by consolidating its European group support functions in Dublin and by aligning with the recently strengthened regulatory regime in Bermuda. With its strong financial position and best in class capabilities in the Group, Monument remains ideally positioned to build on its success to date and grow its European footprint, del

CPAC Systems AB Announces Strategic Minority Investment in Flying Fish9.5.2025 12:33:00 CEST | Press release

Accelerating the shift toward sustainable and intelligent water mobility CPAC Systems AB, a leader in advanced control systems and embedded vessel and commercial vehicle technology, today announced a strategic minority investment in Flying Fish Maritime Innovations B.V., a pioneer in advanced shared water mobility solutions and robust, cost-effective hydrofoil technology. The investment underscores both companies’ commitment to redefining water-based transportation through innovation, sustainability, and seamless integration. It marks the beginning of a deeper collaboration aimed at enabling smarter, cleaner, and more connected mobility on the water — for both recreational and commercial applications. “We are thrilled to support Flying Fish and their impressive work in redefining water mobility,"saidMarcus Wingolf, CEO of CPAC Systems. "Our investment in Flying Fish represents a strategic alignment of our technical proficiencies and innovative ambitions. This partnership opens exciting

Kioxia Receives IEEE Corporate Innovation Award9.5.2025 09:00:00 CEST | Press release

Kioxia Corporation, a world leader in memory solutions, today announced that it has received the IEEE Corporate Innovation Award from the Institute of Electrical & Electronics Engineers (IEEE), the world’s largest technical professional organization dedicated to advancing technology for the benefit of humanity. This award recognizes Kioxia's outstanding contribution in the field of electrical and electronics engineering through its BiCS FLASH™ technology, a low-cost, high-capacity 3D flash memory innovation. The award ceremony was held on April 24 in Tokyo. The IEEE Corporate Innovation Award is a globally-recognized honor bestowed upon organizations that have developed innovative technologies, products or services that have made a substantial contribution to the advancement of electrical and electronics engineering. Since its inception in 1985, the award has been presented to leading electronics manufacturers and IT companies worldwide, and Kioxia is proud to be the seventh Japanese c

Suzano Reports Record First-Quarter Revenue9.5.2025 02:12:00 CEST | Press release

Suzano, the world’s largest pulp producer, announces its first quarter results for 2025 (1Q25) with record net revenue of R$11.6 billion, up 22% on the same quarter last year (1Q24). The result was driven by the exchange rates, increased pulp sales volumes from the new Ribas do Rio Pardo mill, higher paper volume and prices and the positive contribution from our paperboard mills recently acquired in the U.S. The record revenues occurred despite a series of planned downtimes in the quarter, including production lines of the Três Lagoas Unit, Mucuri Unit, and Aracruz Unit, and the Ribas do Rio Pardo Unit’s first scheduled maintenance downtime. Sales exceeded 3 million tonnes in the quarter, a rise of 12% compared to 1Q24, comprising 2.7 million tonnes of pulp and 390 thousand tonnes of paper, up 10% and 25%, respectively, on the same quarter last year. Adjusted EBITDA totaled R$4.9 billion, a 7% increase over 1Q24. Operating cash generation totaled R$2.6 billion, rising 5% on 1Q24. Net p

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye